Repligen | RGEN - Выручка от реализации





Продажи Изменить Дата
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.06B 20M 2026-06
Bio Techne USD 321.2M 9.8M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Bruker USD 838.5M 15.1M 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
General Electric Aerospace USD 12.63B 1.03B 2026-06
Henry Schein USD 3.46B 90M 2026-06
Illumina USD 1.16B 70M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pfizer USD 15.03B 530M 2026-06
Repligen USD 204M 10M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Standard Biotools USD 21.1M 2.7M 2026-03
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Waters USD 1.64B 370M 2026-06
West Pharmaceutical Services USD 872.3M 27.4M 2026-06